Key result
Bioresorbable polymer stents had comparable rates of cardiac death and MI to second-generation durable polymer stents, but higher TVR at ≥5 years.
Why the study?
Literature comparing bioresorbable-polymer stents and second-generation durable-polymer stents in PCI for all-comer CAD was conflicting.
Do bioresorbable-polymer-stents reduce adverse cardiac events compared to second-generation durable-polymer-stents in patients with all comer CAD undergoing PCI?
Meta-Analysis (n=31,822)
Do bioresorbable-polymer-stents reduce adverse cardiac events compared to second-generation durable-polymer-stents in patients with all comer CAD undergoing PCI?
Bioresorbable-polymer-stents and second-generation durable-polymer-stents have comparable overall clinical outcomes in CAD patients undergoing PCI, though BPS may be associated with higher target-vessel revascularization at 5 or more years.
Answers are grounded in this paper and cite their sources.
May favor durable polymer stents to minimize late TVR; confirms comparable safety but questions bioresorbable advantages at ≥5 years.
Background Literature on bioresorbable-polymer-stents (BPS) and second-generation durable-polymer-stents (DPS) in percutaneous coronary intervention (PCI) for all comer CAD is conflicting.Methods Randomized controlled studies comparing PCI among BPS and second-generation DPS were identified up until May-2020 from online databases. Primary outcomes included are all-cause myocardial infarction (MI), cardiac-death, target-vessel-revascularization (TVR), target-vessel MI (TVMI), and stent-thrombosis (ST). Random effect method of risk ratio and confidence interval of 95% was used.Results 25 prospective randomized controlled trials with 31,822 patients (BPS n = 17,065 and DPS n = 14,757) were included in the study. Follow–up ranged between a minimum of 6 months to more than 5 years. Cardiac death (RR 1.02, 95% CI 0.89–1.45, p = 0.16) was comparable in BPS and second-generation DPS. Risk of all-cause MI was similar between BPS and DPS (RR 0.97, 95% CI 0.84–1.11, p = 0.73). TVMI (RR 0.88, 95% CI 0.69–1.11, p = 0.33) and ST rates were also comparable in BPS and DPS groups (RR 1.06, 95% CI 0.80–1.40, p = 1.00). Overall TVR had comparable outcomes between BPS and DPS (RR 0.95, 95% CI 0.79–1.14, p < 0.001); however, higher TVR was seen among BPS group at follow-up of ≥5 years (RR 1.39, 95% CI 1.12-1.14, p = 0.02). Bias was low and heterogeneity was moderate.Conclusion Patients undergoing PCI treated with BPS had comparable outcomes in terms of cardiac death, TVR, ST, TVMI, and all-cause MI to patients treated with second-generation DPS; however, BPS had higher rates of TVR for follow-up of ≥5-years.
No takes yet. Share an insight, caveat, or question.
Mir et al. (2021) conducted a meta-analysis in coronary artery disease (n=31,822). Bioresorbable polymer stents vs. Second-generation durable polymer stents was evaluated on Cardiac death (RR 1.02, 95% CI 0.89-1.45, p=0.16). Bioresorbable polymer stents had comparable rates of cardiac death and MI to second-generation durable polymer stents, but higher TVR at ≥5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: